An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F16%3AN0000047" target="_blank" >RIV/00027162:_____/16:N0000047 - isvavai.cz</a>
Alternative codes found
RIV/60077344:_____/16:00468233
Result on the web
<a href="http://link.springer.com/article/10.1007%2Fs12033-016-9979-1" target="_blank" >http://link.springer.com/article/10.1007%2Fs12033-016-9979-1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12033-016-9979-1" target="_blank" >10.1007/s12033-016-9979-1</a>
Alternative languages
Result language
angličtina
Original language name
An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein
Original language description
To find an effective drug for Zika virus, it is important to understand how numerous proteins which are critical for the virus' structure and function interact with their counterparts. One approach to inhibiting the flavivirus is to deter its ability to bind onto glycoproteins; however, the crystal structures of envelope proteins of the ever-evolving viral strains that decipher glycosidic or drug-molecular interactions are not always available. To fill this gap, we are reporting a holistic, simulation-based approach to predict compounds that will inhibit ligand binding onto a structurally unresolved protein, in this case the Zika virus envelope protein (ZVEP), by developing a three-dimensional general structure and analyzing sites at which ligands and small drug-like molecules interact. By examining how glycan molecules and small-molecule probes interact with a freshly resolved ZVEP homology model, we report the susceptibility of ZVEP to inhibition via two small molecules, ZINC33683341 and ZINC49605556-by preferentially binding onto the primary receptor responsible for the virus' virulence. Antiviral activity was confirmed when ZINC33683341 was tested in cell culture. We anticipate the results to be a starting point for drug discovery targeting Zika virus and other emerging pathogens.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EE - Microbiology, virology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA16-20054S" target="_blank" >GA16-20054S: Advanced studies on West Nile virus infection pathogenesis towards novel therapeutic strategies</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Molecular Biotechnology
ISSN
1073-6085
e-ISSN
—
Volume of the periodical
58
Issue of the periodical within the volume
12
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
801-806
UT code for WoS article
000393123600003
EID of the result in the Scopus database
—